Computational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City University.
HPC- and AI-driven Drug Development Platform Division, Center for Computational Science, RIKEN.
Chem Pharm Bull (Tokyo). 2024;72(11):1005-1013. doi: 10.1248/cpb.c24-00409.
Toll-like receptors (TLRs) play central roles in innate immune defense against infection by binding to microbial molecules. TLR7 and TLR8 are highly homologous sensors with an RNA ligand preference for single-stranded RNA (ssRNA). Recent works reveal that these TLR sense degradation products of RNA at two distinct binding sites, designated 1st site and 2nd site, rather than long ssRNA. The highly conserved 1st site is responsible for the binding of nucleosides and the 2nd site confers the oligonucleotide binding. Binding of the oligonucleotide at the 2nd site synergistically enhances the affinity for nucleoside to the 1st site. However, it remains unclear why these ligands synergistically activate TLR7 and TLR8. Here, we performed a molecular dynamics (MD) calculation and successive decomposition analysis to clarify what this synergistic effect is derived from. We demonstrated that the main factor of the synergistic effect during the TLR7 and TLR8 activation processes was the lowering of the LRR dimerization barrier, mainly achieved by the reduction of the electrostatic repulsion with the oligonucleotide binding at the 2nd site.
Toll 样受体(TLRs)通过与微生物分子结合,在先天免疫防御感染中发挥核心作用。TLR7 和 TLR8 是高度同源的传感器,对单链 RNA(ssRNA)具有 RNA 配体偏好。最近的研究揭示,这些 TLR 在两个不同的结合位点识别 RNA 的降解产物,分别称为第一结合位点和第二结合位点,而不是长 ssRNA。高度保守的第一结合位点负责核苷的结合,第二结合位点赋予寡核苷酸的结合。第二结合位点的寡核苷酸结合协同增强了对第一结合位点核苷的亲和力。然而,尚不清楚为什么这些配体协同激活 TLR7 和 TLR8。在这里,我们进行了分子动力学(MD)计算和连续分解分析,以阐明这种协同作用的来源。我们证明,TLR7 和 TLR8 激活过程中协同作用的主要因素是降低 LRR 二聚化势垒,主要通过降低第二结合位点寡核苷酸结合时的静电排斥来实现。